tm
Seeing Is Believing
tm
Seeing Is Believing
OBIO is currently covered by 4 analysts with an average price target of $13.67. This is a potential upside of $9.4 (220.14%) from yesterday's end of day stock price of $4.27.
Orchestra BioMed Holdings's activity chart (see below) currently has 13 price targets and 23 ratings on display. The stock rating distribution of OBIO is 91.67% BUY and 8.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.86% with an average time for these price targets to be met of 13.4 days.
Highest price target for OBIO is $20, Lowest price target is $10, average price target is $14.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 12-Mar-2026. First documented stock forecast 07-Feb-2023.
Currently out of the existing stock ratings of OBIO, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Feb-2023
$20
$15.74 (369.48%)
$20
22 days ago
(12-Mar-2026)
1/7 (14.29%)
$15.62 (356.62%)
57
Buy Since 02-Jan-2025
$12
$7.74 (181.69%)
$11
2 months 25 days ago
(09-Jan-2026)
0/4 (0%)
$7.2 (150.00%)
Buy Since 22-Aug-2024
$10
$5.74 (134.74%)
$12
6 months 30 days ago
(04-Sep-2025)
0/6 (0%)
$7.26 (264.96%)
Hold Since 20-Aug-2025
$12
7 months 14 days ago
(20-Aug-2025)
0/2 (0%)
$8.76 (270.37%)
Buy Since 24-Feb-2023
$15
$10.36 (223.28%)
$15
2 years 4 months 20 days ago
(14-Nov-2023)
1/2 (50%)
$8.17 (119.62%)
10
What is OBIO (Orchestra BioMed Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on OBIO (Orchestra BioMed Holdings) with a proven track record?
Which analyst has the current lower performing score on OBIO (Orchestra BioMed Holdings) with a proven track record?
Which analyst has the most public recommendations on OBIO (Orchestra BioMed Holdings)?
Which analyst is the currently most bullish on OBIO (Orchestra BioMed Holdings)?
Which analyst is the currently most reserved on OBIO (Orchestra BioMed Holdings)?
